Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001104659-25-053170
Filing Date
2025-05-27
Accepted
2025-05-27 20:53:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2832
  Complete submission text file 0001104659-25-053170.txt   4587
Mailing Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107
Business Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107 817-984-5964
BIOS Fund II QP, LP (Reporting) CIK: 0001716869 (see all company filings)

EIN.: 822743166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39318 | Film No.: 25990657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)